Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03162536
What this trial is testing

Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Who this might be right for
Lymphoma, B-CellSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia+6 more
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 190
Large-scale testing (Phase 3)Study completedNCT00564512
What this trial is testing

Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

Who this might be right for
Leukemia
French Innovative Leukemia Organisation 178
Not applicableWithdrawnNCT01069432
What this trial is testing

Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Study completedNCT01558167
What this trial is testing

A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 22
Testing effectiveness (Phase 2)Ended earlyNCT03572634
What this trial is testing

Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL

Who this might be right for
Chronic Lymphocytic LeukemiaCLLSLL+1 more
Sumitomo Pharma America, Inc. 3
Not applicableStudy completedNCT01768845
What this trial is testing

Unrelated Umbilical Cord Blood (UBC)Transplantation

Who this might be right for
Chronic Myelogenous Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome+6 more
West Virginia University 34
Testing effectiveness (Phase 2)Study completedNCT00541034
What this trial is testing

Pentostatin, Cyclophosphamide, and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 49
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00114257
What this trial is testing

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00022581
What this trial is testing

Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent Grade 1 Follicular LymphomaRecurrent Grade 2 Follicular LymphomaRecurrent Grade 3 Follicular Lymphoma+1 more
National Cancer Institute (NCI) 45
Testing effectiveness (Phase 2)UnknownNCT00026429
What this trial is testing

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Pharmatech Oncology
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT05057494
What this trial is testing

Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
AstraZeneca 607
Large-scale testing (Phase 3)Study completedNCT00262795
What this trial is testing

Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 206
Not applicableEnded earlyNCT00038883
What this trial is testing

Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid Malignancies

Who this might be right for
Leukemia, Lymphocytic, ChronicLeukemia, Lymphocytic, AcuteLymphoma, Low-Grade+2 more
M.D. Anderson Cancer Center 19
Testing effectiveness (Phase 2)Study completedNCT00439231
What this trial is testing

Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma
Georg Aue, M.D. 33
Testing effectiveness (Phase 2)Study completedNCT00001637
What this trial is testing

Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults

Who this might be right for
Chronic Lymphocytic LeukemiaGraft vs Host DiseaseLeukemia+2 more
National Heart, Lung, and Blood Institute (NHLBI) 28
Not applicableActive Not RecruitingNCT05645172
What this trial is testing

Retention Rate of Acalabrutinib in a Non-interventional Setting

Who this might be right for
Chronic Lymphocytic Leukaemia (CLL)
AstraZeneca 137
Testing effectiveness (Phase 2)Study completedNCT00004145
What this trial is testing

Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of Chicago 16
Testing effectiveness (Phase 2)Study completedNCT02988466
What this trial is testing

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota 78
Next Page